Literature DB >> 23960927

Limbal stem cell disease: Treatment and advances in technology.

Hall F Chew1.   

Abstract

Anterior segment stem cell technology, due to its already well-defined corneal limbal stem cells with greater ease of evaluation, has been at the forefront of ophthalmic stem cell treatment and technology since 1997. This paper provides an overview of the current standard of care for treatment of limbal stem-cell deficient conditions and reviews recent treatment technologies using ex vivo expansion of cultivated limbal stem cells of the cornea.

Keywords:  Cornea; Cultured cells; Limbal stem cell deficiency; Stem cell transplantation

Year:  2011        PMID: 23960927      PMCID: PMC3729922          DOI: 10.1016/j.sjopt.2011.04.012

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  47 in total

Review 1.  Limbal stem cells of the corneal epithelium.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Surv Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 6.048

Review 2.  Mesenchymal stem cells and potential applications in treating ocular disease.

Authors:  Aaron W Joe; Kevin Gregory-Evans
Journal:  Curr Eye Res       Date:  2010-11       Impact factor: 2.424

Review 3.  Management of ocular stem cell disease.

Authors:  Joseph M Biber; Edward J Holland; Kristiana D Neff
Journal:  Int Ophthalmol Clin       Date:  2010

4.  Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation.

Authors:  Tsutomu Inatomi; Takahiro Nakamura; Noriko Koizumi; Chie Sotozono; Norihiko Yokoi; Shigeru Kinoshita
Journal:  Am J Ophthalmol       Date:  2006-02       Impact factor: 5.258

5.  Plasma polymer coated surfaces for serum-free culture of limbal epithelium for ocular surface disease.

Authors:  Maria Notara; N A Bullett; Palavi Deshpande; David B Haddow; Sheila MacNeil; Julie T Daniels
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

Review 6.  In sickness and in health: Corneal epithelial stem cell biology, pathology and therapy.

Authors:  M Notara; A Alatza; J Gilfillan; A R Harris; H J Levis; S Schrader; A Vernon; J T Daniels
Journal:  Exp Eye Res       Date:  2009-10-17       Impact factor: 3.467

7.  Living related conjunctival limbal allograft for the treatment of stem cell deficiency.

Authors:  S M Daya; F A Ilari
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

8.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

9.  Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium.

Authors:  G Pellegrini; C E Traverso; A T Franzi; M Zingirian; R Cancedda; M De Luca
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

Review 10.  Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results.

Authors:  Alex J Shortt; Genevieve A Secker; Maria D Notara; G Astrid Limb; Peng T Khaw; Stephen J Tuft; Julie T Daniels
Journal:  Surv Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 6.048

View more
  2 in total

1.  In vitro reconstruction and characterization of tissue-engineered human corneal epithelium with seeder cells from an untransfected human corneal epithelial cell line.

Authors:  Bin Xu; Ting-Jun Fan; Hong-Shou Yang; Ai Sun; Jun Zhao; Xi-Ya Ma; Xiu-Zhong Hu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Transplantation of tissue-engineered human corneal epithelium in limbal stem cell deficiency rabbit models.

Authors:  Bin Xu; Ting-Jun Fan; Jun Zhao; Ai Sun; Rui-Xin Wang; Xiu-Zhong Hu; Hao-Ze Yu; Xian-Yuan Fan; Xiao-Hui Xu
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.